Catalyst Wire Dossier Catalyst Wire Dossier

Norgestimate/Ethinyl estradiol oral contraceptive

ethinyl estradiol; norgestimate · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Drug timelines are a Plus or Pro feature.

2 regulatory and trial events tracked for Norgestimate/Ethinyl estradiol oral contraceptive, covering 2011-06-08 to 2020-09-02. Get the full timeline:

Most recent: Clinical Trial Update: Study to Evaluate Effect of Sofosbuvir/Velpatasvir/GS-9857 Fixed-Dose Combination on the Pharmacokinetics of a Representative Hormonal Contraceptive Medication, Norgestimate/Ethinyl Estradiol [Phase 1]

See pricing